Pemphigus foliaceus (pemphigus vulgaris) is an autoimmune disease characterized by the formation of painful blisters on the skin and mucous membranes. The main cause of this disease is a malfunction of the immune system, which leads to the formation of antibodies against the intercellular structures of the skin, which, in turn, causes the exfoliation of the upper layer of the epidermis. Pemphigus foliaceus most often occurs in adults, especially over 50 years of age, but can also occur in young people. The clinical picture includes not only dermatological manifestations, but also possible systemic complications. In the treatment of this condition, it is important to take into account the individual characteristics of the patient, as well as the stage of the disease.
History of the disease and interesting historical facts
Pemphigus foliaceus was first described in medical literature at the beginning of the 20th century. The most significant contribution to the study of this disease was the description of immunohistological and pathomorphological changes occurring in the skin. In the 1960s, the connection between pemphigus and autoimmune processes became known, which significantly changed the approaches to its diagnosis and treatment. Interestingly, it was thanks to the study of pemphigus that scientists made significant strides in understanding the mechanisms of autoimmune diseases. In addition, pemphigus foliaceus was often mentioned in reports at international conferences, which allowed doctors to exchange experiences and find new treatment methods.
Epidemiology
According to various epidemiological studies, the prevalence of pemphigus foliaceus varies depending on the geographic region. About 0.5-3 cases per 100,000 population are registered annually in Europe and North America, which makes the disease quite rare. In recent decades, there has been an increase in the number of cases, which may be due to both improved diagnostics and an increase in morbidity due to increased stress and changing living conditions. According to studies conducted in the United States, 75% cases occur in people over 50 years of age, and there is a slight predominance of the disease in women compared to men.
Genetic predisposition to this disease
According to the analysis, several genes involved in the pathogenesis of pemphigus foliaceus have been identified, including HLA-DQ2 and HLA-DQ8, which are associated with immune responses. Mutations in these genes contribute to the disruption of antigen expression and the formation of autoantibodies, which is critical in the development of the disease. Familial cases of pemphigus are also observed, indicating possible heredity. Studies show that having a related species with an autoimmune disease significantly increases the risk of developing pemphigus.
Risk factors for the development of this disease
There are a number of factors that contribute to the development of pemphigus foliaceus:
- Age: the disease mainly occurs in patients over 50 years of age.
- Gender: This disease occurs somewhat more often in women than in men.
- Having autoimmune diseases: Diseases such as autoimmune thyroiditis or systemic lupus erythematosus, which increase the risk of pemphigus.
- Infectious factors: Some viral infections can serve as triggers for the development of autoimmune reactions.
- Pharmacological drugs: Certain medications may cause an exacerbation of the disease in predisposed patients.
Diagnosis of this disease
The diagnosis of pemphigus foliaceus is based on clinical manifestations and laboratory tests. The main symptoms include:
- Formation of large sterile blisters on the skin and mucous membranes;
- Pain and itching in the affected area;
- Erythema around the blisters;
- Skin detachment.
Laboratory tests include:
- Immunofluorescence assay for detection of autoantibodies;
- Histopathological examination of skin samples.
Radiological examinations are generally not used. Differential diagnosis may include such diseases as dermatitis, eczema, toxic-allergic reactions.
Treatment
Treatment of pemphigus foliaceus requires a comprehensive approach and includes the following methods:
- General treatment: avoid triggers and stress;
- Pharmacological treatment: corticosteroids, immunosuppressants;
- Surgical treatment: in rare cases, it is possible to remove the affected areas during an exacerbation;
- Other types of treatment: phototherapy, plasmapheresis.
List of medications used to treat this disease
- Prednisolone;
- Azathioprine;
- Methotrexate;
- Cyclosporine;
- Dapsone;
- Retinoids.
Disease monitoring
Monitoring the condition of a patient with pemphigus foliaceus includes:
- Regular examinations by a dermatologist to monitor the dynamics of the disease;
- Laboratory tests to evaluate the effect of drugs;
- Predicting complications such as infections or the development of other autoimmune diseases;
- Teaching the patient self-monitoring and self-examination.
Age-related features of the disease
Pemphigus foliaceus may present differently in different age groups:
- In elderly patients, the disease often has a more severe course and requires intensive treatment;
- Younger patients may have less severe symptoms and respond better to therapy;
- Children, although less likely to be affected by the disease, can experience significant stress due to the manifestations of pemphigus.
Questions and Answers
- What is pemphigus foliaceus? Pemphigus foliaceus is an autoimmune disease that causes painful blisters on the skin due to a malfunction of the immune system.
- What are the main symptoms of pemphigus foliaceus? The main symptoms include the formation of large sterile blisters, itching, soreness and peeling of the skin.
- How is pemphigus foliaceus diagnosed? Diagnosis includes clinical examination, immunofluorescence analysis and histopathological examination.
- How is pemphigus foliaceus treated? Treatment includes the use of corticosteroids, immunosuppressants, and, in some cases, phototherapy.
- What is the prognosis for patients with pemphigus foliaceus? The prognosis depends on age and stage of the disease, but with adequate treatment, most patients can achieve good remission.
